SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: Biotech Jim who wrote (11051)2/27/2017 7:44:45 PM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 12215
 
JUNO, or any other....anything can happen tomorrow. I am hedging today gains,...I am skeptical.



To: Biotech Jim who wrote (11051)3/28/2017 9:32:10 AM
From: tuck  Read Replies (1) | Respond to of 12215
 
CARA: Obviously, nice to see good p values, but given that there were three doses in the UP trial, why no breakout by dose or dose response data? It would be a little easier for this trial to read through to the pain trials with such data, no? Anybody listen to the CC and hear dose response addressed?

TIA & Cheers, Tuck


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News